Randomized placebo-controlled phase III trial of interferon beta-1a in the treatment of disease progression in relapsing MS.
Phase of Trial: Phase III
Latest Information Update: 23 Jun 2015
At a glance
- Drugs Interferon beta-1a (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 23 Jun 2015 Results of ADVANCE and MSCRG studies presented at the 1st Congress of the European Academy of Neurology.
- 05 Nov 2010 New trial record.